Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to 0.52%.

  • Tg Therapeutics' Return on Assets rose 5500.0% to 0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.52%, marking a year-over-year increase of 5500.0%. This contributed to the annual value of 0.05% for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, Tg Therapeutics' Return on Assets is 0.52%, which was up 5500.0% from 0.09% recorded in Q2 2025.
  • Over the past 5 years, Tg Therapeutics' Return on Assets peaked at 0.52% during Q3 2025, and registered a low of 1.11% during Q4 2022.
  • Its 5-year average for Return on Assets is 0.43%, with a median of 0.54% in 2021.
  • As far as peak fluctuations go, Tg Therapeutics' Return on Assets tumbled by -4200bps in 2022, and later skyrocketed by 12200bps in 2024.
  • Tg Therapeutics' Return on Assets (Quarter) stood at 0.89% in 2021, then dropped by -25bps to 1.11% in 2022, then soared by 103bps to 0.04% in 2023, then increased by 5bps to 0.04% in 2024, then surged by 1189bps to 0.52% in 2025.
  • Its Return on Assets was 0.52% in Q3 2025, compared to 0.09% in Q2 2025 and 0.06% in Q1 2025.